SP

Sachin Prakash Satpute

Active Director Additional Director DIN 11285816
DIN 11285816 First appointment Sep 2025 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Sep 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Sachin Prakash Satpute

Data last updated:

Sachin Prakash Satpute is an Additional Director at 5 Milligram Pharmaceuticals Private Limited (since 2025). The company operates in Pharma.

DIN 11285816
Primary Designation Additional Director
Industry Pharma
First Appointment 08 Sep 2025

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Additional Director08 Sep 2025Active

Board colleagues of Sachin Prakash Satpute

NameDINCompanyDesignation
Vikas Anand Singh102367685 Milligram Pharmaceuticals Private LimitedAdditional Director

Directorship timeline

Open interactive timeline →
5 Milligram Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Sachin Prakash Satpute

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sachin Prakash Satpute

Sachin Prakash Satpute currently holds 1 directorship: 5 Milligram Pharmaceuticals Private Limited (Additional Director, since 08 Sep 2025).

Sachin Prakash Satpute was first appointed on 08 Sep 2025 as Additional Director at 5 Milligram Pharmaceuticals Private Limited.

The current boards of Sachin Prakash Satpute's companies include Vikas Anand Singh (5 Milligram Pharmaceuticals Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available